2 hybrid-integrating

Richard Buckholz of Glaxo has made integrating forms of the LexA-fusion
plasmid (pEG202) and the activation domain fusion plasmid (JG4-5) that
are used in the Brent two-hybrid system. He has tested both, and claims
they work beautifully. I have them available for free distribution:
email me.
Erica